Literature DB >> 18304307

Gene array and real time PCR analysis of the adrenal sensitivity to adrenocorticotropic hormone in pig.

Dominique Hazard1, Laurence Liaubet, Magali Sancristobal, Pierre Mormède.   

Abstract

BACKGROUND: Variability in hypothalamic-pituitary-adrenal (HPA) axis activity has been shown to be influenced by genetic factors and related to great metabolic differences such as obesity. The aim of this study was to investigate molecular bases of genetic variability of the adrenal sensitivity to ACTH, a major source of variability, in Meishan (MS) and Large White (LW) pigs, MS being reported to exhibit higher basal cortisol levels, response to ACTH and fatness than LW. A pig cDNA microarray was used to identify changes in gene expression in basal conditions and in response to ACTH stimulation.
RESULTS: Genotype and/or ACTH affected the expression of 211 genes related to transcription, cell growth/maintenance, signal transduction, cell structure/adhesion/extra cellular matrix and protein kinase/phosphatase activity. No change in the expression of known key regulator proteins of the ACTH signaling pathway or of steroidogenic enzymes was found. However, Mdh2, Sdha, Suclg2, genes involved in the tricarboxylic acid (TCA) pathway, were over-expressed in MS pigs. Higher TCA cycle activity in MS than in LW may thus result in higher steroidogenic activity and thus explain the typically higher cortisol levels in MS compared to LW. Moreover, up-regulation of Star and Ldlr genes in MS and/or in response to ACTH suggest that differences in the adrenal function between MS and LW may also involve mechanisms requisite for cholesterol supply to steroidogenesis.
CONCLUSION: The present study provides new potential candidate genes to explain genetic variations in the adrenal sensitivity to ACTH and better understand relationship between HPA axis activity and obesity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18304307      PMCID: PMC2289818          DOI: 10.1186/1471-2164-9-101

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


Background

The hypothalamic-pituitary-adrenal (HPA) axis and more particularly the adrenal gland constitute a principal node of the mammalian endocrine system. The main function of the adrenal cortex is to produce glucocorticoids (cortisol in pig) and mineralocorticoids under the influence of pituitary adrenocorticotropic hormone (ACTH). Adrenal hormones, essential for survival, play important roles in stress responses, metabolism regulation, immunity, reproduction, water and salt balance and various brain functions [1]. Large variations in HPA axis activity (i.e. basal and in response to stress) have been related to genetic factors (in human [2], in mice [3], in rats [4-6], in pigs [7] and in birds [8-10]). Variations in HPA axis activity are also related to important metabolic differences. For example, human abdominal obesity has been associated with alterations in HPA axis functioning [11,12]. In a recent experiment comparing five genetic stocks of pigs (Large White, Landrace, Duroc, Meishan and Piétrain), a positive relationship between cortisol levels in urine (basal and after transportation stress) and body fat content was found both within and across breeds [13]. In addition, Meishan pigs have been reported to exhibit higher basal cortisol levels, response to ACTH and body fat content than Large White pigs [7,14]. Meishan and Large White lines of pigs thus constitute a valuable biological model to investigate the relationship between HPA axis activity and metabolic regulation. Among the different genetic mechanisms involved in HPA axis activity variability [15], several experimental findings suggest that sensitivity to ACTH is a major target in human [16] and in rats [4,17]. In the pig, genetic-based differences in cortisol secretion were shown in response to corticotropin-releasing hormone (CRH) although the ACTH response did not differ among individuals [18]. Moreover, metabolic clearance of cortisol bears no relationship to the cortisol response to ACTH [19]. Previous findings [14] indicate that the difference in HPA axis activity between LW and MS pigs may originate from the adrenal gland although these breeds also differ in corticosteroid-binding globulin (CBG) levels that influence circulating levels of cortisol [20]. In this study, we explore the molecular mechanism responsible for the difference in adrenal sensitivity to ACTH in MS and LW pigs. The actions of ACTH in the adrenal cortex are mediated via two temporally distinct pathways. Acute and chronic regulation of steroidogenesis occur within minutes and hours, respectively [21,22]. The acute response is initiated by the mobilization and delivery of the substrate, cholesterol, for steroid hormone biosynthesis from the outer to the inner mitochondrial membrane, where it is metabolized to pregnenolone by the cytochrome P450 cholesterol side chain cleavage enzyme (P450scc) [23]. The slower, long-lasting response to ACTH directs transcription of genes encoding the steroidogenic enzymes [22,24]. Most studies of ACTH action have focused on the long term induction (several hours) of transcripts either by investigating transcripts with specific functions in steroidogenesis [22,24] or by genome-wide analysis [25-27]. However, the acute response to ACTH stimulation has been reported to require de novo protein synthesis (for review see ref. [21]). The steroidogenic acute regulatory protein (StAR), that is responsible for the transfer of cholesterol from the outer to the inner mitochondrial membrane, has been proposed to be the rate-limiting and regulated step in steroidogenesis [23,28]. Changes in Star gene expression induced by ACTH have been observed as early as 30 min and were maximally elevated between 1 and 3 h [29]. On the other hand, cortisol responses to ACTH injections in Meishan and Large White pigs have been reported to be at maximum levels at 1 hour [14,30]. Taking together these findings, we hypothesized that transcriptional regulation may in fact take place in the acute response to ACTH, i.e. within 1 hour, in both lines of pigs. Differences in transcriptional regulation at the adrenal gland could already exist between both genotypes in basal conditions because basal cortisol levels are typically greater in MS pigs. Considering the findings described above and the literature concerning acute regulation of transcripts by ACTH in adrenals, we undertook a microarray analysis of gene expression in the adrenal glands of MS and LW pigs under basal conditions and in response to acute stimulation by ACTH. The aim of this study was to investigate the molecular bases of the genetic differences in adrenal sensitivity to ACTH. We found that genotype and/or ACTH affected the expression of 211 genes which provide new potential candidate genes to explain genetic variations in the adrenal sensitivity to ACTH.

Results

Cortisol levels

Comparison of plasma cortisol concentrations (figure 1) in control and ACTH-injected pigs showed significant breed (p < 0.0001) and treatment (p < 0.0001) effects and significant interaction (p ≤ 0.001). In control animals, basal cortisol levels were higher in Meishan pigs than in Large White pigs. Injection of ACTH increased cortisol levels in both genotypes but to a larger extent in Large White than in Meishan pigs.
Figure 1

Cortisol concentrations (ng/ml plasma). Cortisol concentrations (ng/ml plasma) measured in Large White (LW) and Meishan (MS) piglets either untreated (control) or 1 hour after injection (ACTH) of a high dose (250 μg per animal) of 1–24 ACTH (Immediate synacthen). (n = 6 per experimental group, means ± SE).

Cortisol concentrations (ng/ml plasma). Cortisol concentrations (ng/ml plasma) measured in Large White (LW) and Meishan (MS) piglets either untreated (control) or 1 hour after injection (ACTH) of a high dose (250 μg per animal) of 1–24 ACTH (Immediate synacthen). (n = 6 per experimental group, means ± SE).

Gene transcript regulation by genotype and ACTH treatment

Using the normalization process described in the methods section, 3496 of the 8959 transcripts present on the pig cDNA array (approximately 40%) were found to be expressed in adrenal glands in our experimental conditions. Using the criterion of < 5% FDR, 241 transcripts were identified to be significantly up-regulated or downregulated by genotype and/or ACTH challenge (see additional file 1). Among these, 211 transcripts corresponded to unique annotated transcripts (five present twice) and 25 remained unknown. These 241 transcripts were categorized according to the genotype and/or treatment effect and ordered by absolute fold change. Table 1 lists transcripts most significantly affected by genotype and/or treatment at p < 0.0001. Among these, 51 transcripts were significantly affected by genotype (39 transcripts up-regulated and 12 down regulated in Meishan), 21 transcripts were significantly affected by ACTH treatment (12 transcripts up-regulated and six down regulated in response to ACTH treatment) and 36 transcripts were significantly affected by both genotype and ACTH treatment. The major functional categories for these genes included transcription regulation, cell growth/maintenance, signal transduction, structural/cell adhesion/ECM and protein kinase activity.
Table 1

Genes differentially expressed depending on genotype and/or ACTH treatment

Gene symbolGene nameGene Functionp-value (ANOVA)Fold Change

genotype: MS/LWtreatment: ACTH/control

genotypetreatmentinteractioncontrolACTHLWMS
Genes up-regulated in Meishan pigs

Rnf2ring finger protein 2Transcription regulation2.81E-137.89E-011.96E-023.52.51.2-1.2
Mdkmidkine (neurite growth-promoting factor 2)Cell growth/maintenance4.97E-06NSNS2.01.51.2-1.1
Snf1lkSNF1-like kinaseProtein Kinase activity8.19E-05NSNS1.81.81.21.3
Ccnd1cyclin D1Cell growth/maintenance9.83E-06NSNS1.71.51.11.0
Cd99CD99 moleculeStructural/Cell adhesion/ECM1.01E-05NSNS1.71.61.01.0
Col21a1collagen, type XXI, alpha 1Structural/Cell adhesion/ECM9.39E-05NSNS1.71.5-1.0-1.2
Gprc5bG protein-coupled receptor, family C, group 5, member BSignal transduction (glutamatergic)9.53E-07NSNS1.61.51.1-1.0
Ldhdlactate dehydrogenase DATP biosynthesis3.77E-06NSNS1.61.61.11.1
Ppp1r1aprotein phosphatase 1, regulatory (inhibitor) subunit 1APhosphatase inhibitor8.18E-06NSNS1.61.4-1.0-1.2
Mrps6mitochondrial ribosomal protein S6Translation1.25E-06NSNS1.61.41.1-1.1
Traf5TNF receptor-associated factor 5Signal transduction5.80E-05NSNS1.51.51.01.0
Cse1lCSE1 chromosome segregation 1-like (yeast)Protein transport2.98E-06NSNS1.51.41.11.0
Hist2h2aahistone cluster 2, H2aa4Nucleosome Assembly2.10E-05NSNS1.51.5-1.1-1.1
Cd99CD99 moleculeStructural/Cell adhesion/ECM2.27E-05NSNS1.51.6-1.11.0
Mifmacrophage migration inhibitory factor (glycosylation-inhibiting factor)Cell growth/maintenance1.25E-05NSNS1.51.31.1-1.0
Ptpmt1protein tyrosine phosphatase, mitochondrial 1Protein Phosphatase activity1.73E-08NSNS1.51.51.01.1
Mdh2malate dehydrogenase 2, NAD (mitochondrial)Tricarboxylic acid cycle2.59E-06NSNS1.51.51.01.1
Malat1metastasis associated lung adenocarcinoma transcript 1 (non coding RNA)unknown4.07E-05NSNS1.51.3-1.0-1.2
Suclg2succinate-CoA ligase, GDP-forming, beta subunitTricarboxylic acid cycle1.82E-05NSNS1.41.31.0-1.1
Eif3s7eukaryotic translation initiation factor 3, subunit 7 zeta, 66/67kDaTranslation regulation4.61E-055.87E-012.64E-021.41.11.1-1.2
Magi3membrane associated guanylate kinase, WW and PDZ domain containing 3Protein Kinase activity2.40E-05NSNS1.41.8-1.21.0
Ppap2bphosphatidic acid phosphatase type 2BProtein Phosphatase activity3.45E-056.74E-024.48E-021.42.2-1.01.5
Cys1cystin 1unknown1.08E-08NSNS1.41.5-1.1-1.0
Txnl2thioredoxin-like 2Electron transport5.63E-05NSNS1.41.31.01.0
C8orf53chromosome 8 open reading frame 53unknown1.34E-05NSNS1.41.41.11.1
C14orf2chromosome 14 open reading frame 2unknown1.65E-05NSNS1.41.31.0-1.0
Dusp26dual specificity phosphatase 26 (putative)unknown3.78E-06NSNS1.41.41.01.0
Sod2superoxide dismutase 2, mitochondrialSuper oxide metabolism1.61E-06NSNS1.41.5-1.1-1.0
Ssr3signal sequence receptor, gamma (translocon-associated protein gamma)Cotranslational membrane targeting7.82E-05NSNS1.41.31.11.0
Xpnpep1X-prolyl aminopeptidase (aminopeptidase P) 1, solubleProteolysis3.05E-05NSNS1.31.3-1.0-1.0
Hint1histidine triad nucleotide binding protein 1Signal transduction6.24E-05NSNS1.31.21.11.0
Hsbp1heat shock factor binding protein 1Transcription regulation6.13E-05NSNS1.31.21.0-1.0
Mrps10mitochondrial ribosomal protein S10Structural constituent of ribosome6.05E-05NSNS1.31.3-1.01.0
LppLIM domain containing preferred translocation partner in lipomaunknown4.71E-05NSNS1.21.31.11.1
Pgk1phosphoglycerate kinase 1Protein Kinase activity1.83E-05NSNS1.21.4-1.11.1
Ppap2dphosphatidic acid phosphatase type 2dProtein Phosphatase activity6.15E-06NSNS1.21.3-1.01.1
Atp5bATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptideATP biosynthesis1.07E-05NSNS1.21.11.0-1.0
Ccnycyclin Yunknown1.59E-05NSNS1.21.31.01.1
Cox6b1cytochrome c oxidase subunit Vib polypeptide 1 (ubiquitous)Oxydoreductase activity9.02E-05NSNS1.21.3-1.01.1

Genes down-regulated in Meishan pigs

C1qacomplement component 1, q subcomponent, A chainCell-cell signaling3.08E-06NSNS-2.1-1.5-1.11.2
Cited1Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1Transcription regulation1.88E-10NSNS-1.8-2.01.1-1.0
Tmem14ctransmembrane protein 14CStructural/Cell adhesion/ECM (mito)4.24E-064.81E-014.54E-02-1.8-1.3-1.21.1
Hmgb3high-mobility group box 3Transcription regulation2.00E-08NSNS-1.6-1.4-1.2-1.0
Tmem14ctransmembrane protein 14CStructural/Cell adhesion/ECM (mito)5.40E-093.37E-011.61E-02-1.6-1.3-1.11.1
Bphlbiphenyl hydrolase-like (serine hydrolase; breast epithelial mucin-associated antigen)Amino acid metabolism2.71E-06NSNS-1.5-1.4-1.1-1.0
Ttll12tubulin tyrosine ligase-like family, member 12unknown8.52E-08NSNS-1.5-1.61.1-1.0
Gpx3glutathione peroxidase 3 (plasma)Peroxidase activity8.06E-08NSNS-1.5-1.5-1.0-1.1
Fkbp4FK506 binding protein 4, 59kDaProtein binding4.64E-05NSNS-1.4-1.31.01.1
Gnsglucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID)Glycosaminoglycan catabolism5.48E-05NSNS-1.3-1.51.1-1.1
Nr1h2nuclear receptor subfamily 1, group H, member 2Transcription regulation1.30E-05NSNS-1.2-1.31.0-1.1
H2afjH2A histone family, member JNucleosome Assembly3.50E-05NSNS-1.2-1.3-1.0-1.1

Genes up-regulated by ACTH

Bag3BCL2-associated athanogene 3Cell growth/maintenance3.76E-019.34E-115.19E-031.2-1.33.02.0
Ier3immediate early response 3Cell growth/maintenance4.49E-012.83E-093.81E-021.3-1.12.61.9
Adamts1ADAM metallopeptidase with thrombospondin type 1 motif, 1Cell growth/maintenanceNS2.37E-06NS1.4-1.12.61.7
Gadd45agrowth arrest and DNA-damage-inducible, alphaRegulation of protein kinase activityNS1.46E-07NS1.1-1.12.11.7
Id3inhibitor of DNA binding 3, dominant negative helix-loop-helix proteinTranscription regulationNS4.69E-07NS-1.1-1.22.01.9
Tfpi2tissue factor pathway inhibitor 2Structural/Cell adhesion/ECMNS4.72E-07NS1.11.01.81.7
Odc1ornithine decarboxylase 1Cell growth/maintenanceNS2.85E-06NS1.21.01.61.4
Tomm20translocase of outer mitochondrial membrane 20 homolog (yeast)Protein transport (mb ext mito)NS9.51E-05NS1.21.11.51.4
Timp1TIMP metallopeptidase inhibitor 1Cell growth/maintenanceNS2.88E-07NS1.0-1.11.41.3
Ddx3xDEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linkedRNA helicase activityNS1.19E-05NS1.11.01.41.3
C10orf46chromosome 10 open reading frame 46unknownNS6.70E-06NS1.01.21.41.6
Gnl2guanine nucleotide binding protein-like 2 (nucleolar)unknownNS3.73E-05NS1.1-1.01.31.2

Genes down regulated by ACTH

Stat5asignal transducer and activator of transcription 5ATranscription regulationNS8.12E-05NS-1.01.0-1.4-1.3
Wasf2WAS protein family, member 2Signal transduction (G-protein)NS7.81E-05NS-1.01.0-1.3-1.3
Unc84bunc-84 homolog B (C. elegans)Cell growth/maintenanceNS4.26E-05NS1.2-1.0-1.3-1.6
Cntfciliary neurotrophic factorSignal transductionNS4.93E-05NS-1.01.1-1.3-1.2
Nfe2l2nuclear factor (erythroid-derived 2)-like 2Transcription regulationNS5.59E-06NS1.11.0-1.3-1.3
Pcbd1pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1)Transcription regulationNS5.70E-05NS1.11.0-1.2-1.3
Bmpr2bone morphogenetic protein receptor, type II (serine/threonine kinase)Protein Kinase activityNS3.15E-05NS-1.11.0-1.2-1.1
Ctnnb1catenin (cadherin-associated protein), beta 1, 88kDaTranscription regulationNS1.01E-05NS-1.0-1.1-1.2-1.2
Gdf8growth differentiation factor 8Signal transduction (TGFb)NS5.41E-05NS1.1-1.1-1.2-1.3

Genes upregulated in Meishan and by ACTH

CremcAMP responsive element modulatorTranscription regulation4.34E-022.70E-10NS1.71.14.43.0
Cd83CD83 moleculeSignal transduction6.77E-063.80E-10NS1.91.53.22.6
Eif1beukaryotic translation initiation factor 1BTranslation regulation9.08E-067.89E-10NS1.51.92.53.3
Tob1transducer of ERBB2, 1Transcription regulation4.11E-026.96E-08NS1.11.02.52.3
Ldlrlow density lipoprotein receptor (familial hypercholesterolemia)Cholesterol mobilization5.19E-034.15E-07NS1.61.32.31.8
Chchd2coiled-coil-helix-coiled-coil-helix domain containing 2unknown4.72E-043.36E-06NS1.41.31.61.5
Ckbcreatine kinase, brainStructural/Cell adhesion/ECM1.03E-063.00E-02NS2.11.91.31.2
Mki67ipMKI67 (FHA domain) interacting nucleolar phosphoproteinrRNA metabolism1.25E-049.14E-05NS1.31.31.31.3
Maobmonoamine oxidase BElectron transport4.43E-054.23E-03NS1.41.31.21.2
DnajaDnaJ (Hsp40) homolog, subfamily A, member 2Cell growth/maintenance1.59E-052.55E-03NS1.51.21.21.0
H19H19, imprinted maternally expressed untranslated mRNAunknown9.02E-075.79E-03NS1.51.61.11.3
Dleu1deleted in lymphocytic leukemia, 1Cell growth/maintenance4.90E-072.14E-03NS1.52.01.11.4

Genes up-regulated in Meishan and down-regulated by ACTH

Selenbp1selenium binding protein 1Transporter activity2.98E-051.41E-02NS1.31.5-1.3-1.1
C16orf33chromosome 16 open reading frame 33unknown5.03E-053.98E-02NS1.21.3-1.2-1.0
Ech1enoyl Coenzyme A hydratase 1, peroxisomalFatty acid metabolism5.27E-076.31E-03NS1.41.4-1.2-1.2
Anpepalanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150)Development/Morphogenesis5.65E-128.27E-03NS2.11.9-1.1-1.2
Iscuiron-sulfur cluster scaffold homolog (E. coli)unknown6.09E-051.03E-03NS1.31.2-1.1-1.2
Enpp2ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin)Signal transduction (G-protein)8.22E-056.17E-03NS1.41.3-1.1-1.2
Klhl22kelch-like 22 (Drosophila)unknown2.75E-049.94E-05NS1.31.1-1.1-1.2
Sdhasuccinate dehydrogenase complex, subunit A, flavoprotein (Fp)Tricarboxylic acid cycle3.38E-053.08E-02NS1.21.2-1.0-1.1

Genes down regulated in Meishan and by ACTH

Ctdsp2CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2unknown1.84E-024.68E-08NS-1.1-1.3-1.6-1.8
Pecam1platelet/endothelial cell adhesion molecule (CD31 antigen)Signal transduction2.74E-058.45E-04NS-1.6-1.6-1.4-1.5
Dab2disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)Cell growth/maintenance2.92E-025.63E-05NS-1.1-1.3-1.4-1.7
Cyb5bcytochrome b5 type B (outer mitochondrial membrane)Transporter activity4.15E-032.59E-06NS-1.1-1.3-1.4-1.6
Ostf1osteoclast stimulating factor 1Signal transduction1.66E-071.08E-02NS-1.7-1.5-1.3-1.1
Gdf8growth differentiation factor 8Signal transduction (TGFb)4.95E-036.71E-05NS-1.1-1.3-1.3-1.4
Nfat5nuclear factor of activated T-cells 5, tonicity-responsiveTranscription regulation2.75E-031.27E-05NS-1.2-1.2-1.3-1.3
Acox1acyl-Coenzyme A oxidase 1, palmitoylFatty acid metabolism7.62E-104.31E-04NS-1.7-1.5-1.2-1.1
Ephx1epoxide hydrolase 1, microsomal (xenobiotic)Proteolysis1.60E-062.62E-02NS-1.8-1.6-1.2-1.1
Ccdc85bcoiled-coil domain containing 85Bunknown1.66E-054.54E-02NS-1.6-1.4-1.2-1.1
A2malpha-2-macroglobulinProtein transport2.45E-103.68E-03NS-1.8-1.7-1.2-1.1
Nononon-POU domain containing, octamer-bindingmRNA processing1.01E-063.80E-03NS-1.4-1.3-1.2-1.1
Ifltd1intermediate filament tail domain containing 1unknown6.75E-061.81E-04NS-1.2-1.4-1.2-1.3
Myst4MYST histone acetyltransferase (monocytic leukemia) 4Transcription regulation9.48E-061.18E-02NS-1.3-1.3-1.1-1.2

Genes down regulated in Meishan and up-regulated by ACTH

Gadd45bgrowth arrest and DNA-damage-inducible, betaRegulation of protein kinase activity6.38E-041.41E-11NS-1.3-1.32.42.4
C14orf4chromosome 14 open reading frame 4unknown8.66E-037.41E-05NS-1.0-1.21.41.2

Genes differentially expressed between Meishan (MS) and Large White (LW) pigs and/or in response to acute stimulation by ACTH were identified using a pig cDNA microarray made up of 8959 cDNA clones. The most significant affected genes (p < 0.0001) were listed in the table, categorized on the basis of up or down-regulated by genotype and/or ACTH and sorting by decreasing fold changes. (unknown transcripts were excluded) Complete list is given in the additional file 1.

Genes differentially expressed depending on genotype and/or ACTH treatment Genes differentially expressed between Meishan (MS) and Large White (LW) pigs and/or in response to acute stimulation by ACTH were identified using a pig cDNA microarray made up of 8959 cDNA clones. The most significant affected genes (p < 0.0001) were listed in the table, categorized on the basis of up or down-regulated by genotype and/or ACTH and sorting by decreasing fold changes. (unknown transcripts were excluded) Complete list is given in the additional file 1.

Quantitative analysis

Eleven genes highly significantly affected by genotype and/or treatment factors were selected for further examination by quantitative real-time PCR (Table 2). Changes in transcripts levels were confirmed for nine genes. Correlation coefficients between expression levels as measured with membrane hybridization and real-time PCR were significant (r2 between 0.51 and 0.90, p < 0.05) for 9 out of 11 genes tested (see additional file 2). The magnitudes of the changes were roughly similar between the array and the real-time PCR except for the largest fold-changes (higher than 2 fold) that seemed dampened on the microarrays. An exception was Rnf2 gene, which showed no difference between genotypes of pigs or in response to ACTH when assayed by quantitative RT-PCR, but which exhibited a significant genotype difference when tested against the pig cDNA array. This disparity may have resulted from a false-discovery error or from cross-hybridization of transcripts to region of similarity in the arrayed Rnf2 cDNA. The second exception was Fxc1, which showed no significant difference when assayed by quantitative RT-PCR, but which exhibited a significant genotype difference when tested against the pig cDNA array. However, the fold changes between breeds found on the array were of low magnitude (< 1.5-fold).
Table 2

Measurement of genotype and/or ACTH effects on transcript accumulation by relative quantitative real-time PCR and comparison with microarray data

Gene symbolMicroarrayReal time PCR

p-value (ANOVA)Fold Changep-value (ANOVA)Fold Change

genotype: MS/LWtreatment: ACTH/controlgenotype: MS/LWtreatment: ACTH/control

genotypetreatmentinteractioncontrolACTHLWMSgenotypetreatmentinteractioncontrolACTHLWMS
Rnf22.81E-137.89E-011.96E-023.52.51.2-1.20.820.640.811.1-1.01.11.0
Anpep5.65E-128.27E-03NS2.11.9-1.1-1.2< 0.00010.0400.0563.93.0-1.0-1.4
Gadd45b6.38E-041.41E-11NS-1.3-1.32.42.40.028< 0.00010.33-1.5-1.52.62.6
Eif1b9.08E-067.89E-10NS1.51.92.53.30.009< 0.00010.0401.41.92.94.1
Crem4.34E-022.70E-10NS1.71.14.43.00.18< 0.00010.431.61.36.45.4
A2m2.45E-103.68E-03NS-1.8-1.7-1.2-1.1< 0.00010.110.54-2.1-2.1-1.3-1.2
Ldlr*5.19E-034.15E-07NS1.61.32.31.8NDNDNDNDNDNDND
Ckb1.03E-063.00E-02NS2.11.91.31.20.0040.430.882.32.11.31.2
Dab22.92E-025.63E-05NS-1.1-1.3-1.4-1.70.340.0520.63-1.3-1.2-1.8-1.6
Ldlr*1.50E-021.14E-031.06E-021.51.01.61.10.069< 0.00010.801.41.22.22.0
Fxc13.06E-042.35E-02NS1.21.31.11.10.280.160.48-1.1-1.41.61.2
Star4.85E-04NSNS1.61.21.41.10.0530.260.4061.41.11.31.0
Mc2rNDNDNDNDNDNDND0.950.240.77-1.11.01.21.4
Scarb1NSNSNSNSNSNSNS0.890.250.751.1-1.01.21.1
BzrpNDNDNDNDNDNDND0.0170.640.089-2.3-1.2-1.41.4
SqleNSNSNSNSNSNSNS0.160.390.32-1.1-1.51.3-1.0
Cyp11a1NSNSNSNSNSNSNS0.850.360.371.2-1.11.41.0
Hsd3b1NSNSNSNSNSNSNS0.510.170.94-1.1-1.1-1.3-1.3
Cyp21NSNSNSNSNSNSNS0.0220.900.33-1.2-1.51.1-1.1
Cyp11bNSNSNSNSNSNSNS0.130.270.941.31.31.21.2
Per2NDNDNDNDNDNDND0.460.0400.066-1.21.8-2.3-1.0
Cry1NSNSNSNSNSNSNS0.960.480.621.1-1.11.21.0
Bmal1NDNDNDNDNDNDND0.0020.210.70-2.5-2.9-1.4-1.6

The changes in expression levels for 11 genes shown by microarray analysis to be significantly regulated by genotype and/or ACTH were quantified by real-time PCR. For comparison, relative expression values for each gene were determined in each animal (fold change, n = 6 pigs per experimental point). Changes in expression levels were also analyzed for 11 additional genes of great interest for our study whereas they were either shown by microarray analysis to be not significant (NS, p > 0.05) or not determined (ND) since they were not included on the microarray or due to the data normalization process. * LDLR gene was represented by 2 cDNA clones on the microarray and changes in its expression were verified by real-time PCR using only the cDNA sequence for which exons/introns structure could be deduced.

Measurement of genotype and/or ACTH effects on transcript accumulation by relative quantitative real-time PCR and comparison with microarray data The changes in expression levels for 11 genes shown by microarray analysis to be significantly regulated by genotype and/or ACTH were quantified by real-time PCR. For comparison, relative expression values for each gene were determined in each animal (fold change, n = 6 pigs per experimental point). Changes in expression levels were also analyzed for 11 additional genes of great interest for our study whereas they were either shown by microarray analysis to be not significant (NS, p > 0.05) or not determined (ND) since they were not included on the microarray or due to the data normalization process. * LDLR gene was represented by 2 cDNA clones on the microarray and changes in its expression were verified by real-time PCR using only the cDNA sequence for which exons/introns structure could be deduced. Eleven additional genes involved in ACTH signaling, metabolism and mobilization of cholesterol, steroidogenesis and clock genes that were either not found to be significantly affected by genotype or ACTH treatment (Scarb1, Sqle, Cyp11a1, Hsd3b1, Cyp21, Cyp11b, Cry1) or not present on the array (Mc2r, Bzrp, Per2, Bmal1) were selected for further examination by quantitative real-time PCR because they were interesting for our study (Table 2). The absence of significant changes in the microarray study was confirmed for six out of seven genes. The Mc2r gene that encodes the ACTH receptor was not present on the array. Quantitative real-time PCR showed that the Mc2r gene was not significantly affected by genotype or by ACTH treatment. Inasmuch as the present data showed that two transcripts involved in cholesterol transport (i.e. Ldlr and Star) were significantly affected by genotype and ACTH treatment, changes in the expression of Scarb1 and Bzrp genes, also involved in cholesterol transport, were measured by quantitative RT-PCR. Quantitative RT-PCR analysis showed that genotype and ACTH treatment did not affect the expression of Scarb1. However, the expression of Bzrp gene was found to be greater in Large White pigs whereas Bzrp was not found expressed on the array probably due to the low expression level of this gene and to the data normalization process used in the microarray analysis. Sqle is a key gene involved in an early step of cholesterol biosynthesis de novo. Its expression was not significantly affected by genotype or ACTH on the array. This was confirmed by real-time PCR. Cyp11a1, Hsd3b1, Cyp21 and Cyp11b that encode enzymes involved in steroidogenesis were unaffected by genotype or ACTH on the microarrays. Quantitative RT-PCR confirmed that neither genotype nor ACTH affected the levels of those genes except for Cyp21. While no significant difference was found when tested against the pig cDNA array, expression of Cyp21 was found to be greater in LW pigs when assayed by quantitative RT-PCR, but the fold changes were of low magnitude. Finally, 3 clock genes Per2, Cry1 and Bmal1 reported to be involved in circadian corticosteroids biosynthesis or adrenal responsiveness to ACTH were further investigated by quantitative real-time PCR. No significant change in Cry1 expression on the microarray was confirmed by real-time PCR. The two 2 other clock genes, Per2 and Bmal1, not present on the microarray were found significantly affected by ACTH treatment and genotype, respectively. Per2 was down-regulated in response to ACTH treatment and expression of Bmal1 was greater in LW pigs.

Discussion

We used a comprehensive gene expression profiling by microarray analysis to identify groups of genes differentially expressed by genotype and/or by acute ACTH treatment. This is the first gene array analysis investigating in vivo adrenal response to an acute ACTH stimulation and exploring genetic variability at the adrenal level by using different breeds of pigs (i.e. an interesting biological model because pigs produce cortisol as humans). In microarrays, which included almost 8960 transcripts, the present results indicate that genotype and/or ACTH treatment affected the levels of 211 genes in adrenals. Moreover, although previous gene array analyses of ACTH action have been conducted in vitro and/or focused on the effects of chronic stimulation [25,27], our experiments demonstrate in vivo that acute ACTH treatment affects a large number of transcripts. For the vast majority of affected transcripts, the changes were less than 2-fold excepted for some, probably of great interest, for which changes were as much as 4.5-fold. While some studies reported that small changes may be due to the tendency of microarray analysis to underestimate fold changes in transcripts accumulation [31], comparison of fold changes between microarray and real-time PCR analysis showed the accuracy of nylon microarrays used, even if fold-changes higher than 2-fold seemed to be somewhat underestimated. Our results suggest that genotypic difference and ACTH action may produce relatively small changes in transcript accumulation but these small changes could well be of physiological significance [32]. The dose of ACTH used in our study has been shown to maximally activate cortisol production within one hour [14,30] and thus, may produce maximum effects on steroidogenesis. Cortisol concentrations measured in our study were consistent with previous results reporting that cortisol levels induced by ACTH were higher in Meishans than in Large Whites, as well as basal cortisol levels [7,14]. However, ACTH did not affect gene expression of steroidogenesis enzymes (i.e. Cyp11a1, Cyp17, 3βhsd, Cyp21, Cyp11b). This result is consistent with the fact that acute stimulation by ACTH had little effect on adrenal P450s and steroidogenic enzymes while in contrast, long-term ACTH treatment provokes profound changes in the mRNA levels of many adrenal steroidogenic enzymes [22,29,33]. Interestingly, no differences in expression of steroidogenesis genes were found between Meishan and Large White pigs. These results suggest that the difference of corticosteroidogenesis between Meishan and Large White pigs is not triggered by changes in gene expression of adrenal P450 and 3βHSD enzymes under basal state or following acute ACTH stimulation. Nevertheless, we cannot exclude that steroidogenic activity might be higher in Meishan pigs than in Large White pigs. Indeed, expression of several genes (Mdh2, Sdha and Suclg2) involved in the tricarboxylic acid (TCA) pathway was greater in MS pigs. The main catalytic function of TCA cycle is to provide reducing equivalents to the respiratory complexes [34], for example, steroid hydroxylation [35]. Moreover, the TCA cycle also contributes to the synthesis of heme [34], necessary for the prosthetic groups of the steroidogenic cytochrome P450s [36]. In this respect, it is worth noting that Alas1, the rate-limiting enzyme in heme biosynthesis [37], shows a greater expression in MS than in LW pigs (see additional file 1). These mechanisms may together result in a higher steroidogenic activity by supplying more reducing equivalents and heme to steroidogenic enzymes. This hypothesis is supported by previous observations indicating that heme availability limited adrenal corticosteroid biosynthesis [38] and by recent data showing that acute stimulation of steroid production by ACTH was significantly increased when heme oxygenase activity was inhibited [39]. The effects of ACTH are mediated through the ACTH receptor (MC2R) belonging to the melanocortin receptor family (MCRs). The binding of ACTH to its cognate G protein-coupled receptor promotes the activation of protein kinase A and MAPK-dependent signaling cascades that collectively initiate adrenal-specific steroidogenic transcriptional programs [21,22,40]. Findings from numerous in vitro studies support the notion that ACTH is a positive regulator of ACTH-R mRNA expression [33,41,42]. More particularly, Winnay and Hammer [43] demonstrated in vitro that ACTH stimulation acutely activates the Mc2r gene promoter (i.e. within 80 min). In our study, we showed that ACTH did not affect Mc2r gene expression within 1 hour and that this gene was not differentially expressed between MS and LW pigs. Similarly, no difference in gene expression encoding key regulator proteins of the ACTH signaling pathway (i.e. G protein, Adenylate Cyclase, Protein Kinase A and MAPK ERK1, ERK2) was found in our study. On the other hand, the levels of Crem (cAMP response element modulator), a cAMP-dependent transcription factor that functions to activate genes involved in steroidogenesis [44], were increased in presence of ACTH and higher in MS than LW pigs. Moreover, trophic hormone stimulation of steroidogenic cells has been shown to result in the activation of G proteins that stimulate adenylate cyclase activity and produce increased intracellular levels of cAMP [21]. Thus, high levels of Crem in MS compared to LW and in response to ACTH may result to a larger increase of signal transduction induced by ACTH. A constant supply of cholesterol is required within adrenal cells for steroidogenesis. The rate-limiting step for steroidogenesis is the movement of unesterified cholesterol into mitochondria where it can then be metabolized by CYP11A1 and other enzymes in the steroidogenic pathway (for review see ref. [45]). The movement of cholesterol into the mitochondria is mediated by steroidogenic acute regulatory protein (StAR) [23] and other partners such as peripheral-type benzodiazepine receptor or translocator protein [46]. Interestingly, greater expression of the Star gene in Meishan than in Large White pigs found in our study suggests that enhanced cholesterol transport into mitochondria may contribute to the higher corticosteroid biosynthesis found in MS pigs compared to LW pigs. All studies on StAR function agree that this enzyme mediates acute stimulation of steroidogenesis in response to ACTH administration and requires de novo protein synthesis (for review see ref. [21]). However, we did not find changes in transcript levels of Star 1 h following ACTH treatment while changes in Star gene expression induced by ACTH have been previously observed as early as 30 min and levels were maximally elevated between 1 and 3 h in the rat [29]. Nevertheless, phosphorylation of more preexisting StAR protein in MS pigs, a mechanism involved in the acute response to ACTH stimulation [47], could contribute to the higher cortisol levels induced in response to ACTH in MS than in LW pigs. The unesterified cholesterol needed for steroidogenesis can be derived from several different sources (for review see ref. [45]). In our study we did not find differences in gene expression of enzymes involved in endogenous cellular cholesterol synthesis, such as Sqle or Hmgcr, between genotypes or in response to ACTH while those genes have been reported to be regulated by ACTH [25,27]. On the other hand, cellular cholesterol delivery for steroidogenesis includes uptake of lipoprotein-derived cholesterol via low density lipoprotein (LDL) receptor mediated endocytic pathways and SRB1 (Scavenger Receptor class B, type1) mediated "selective" pathways (for review see ref. [45]). Interestingly we found higher Ldlr expression in MS than in LW pigs and in response to ACTH but no changes were observed in Scarb1 expression. Changes in Ldlr expression in response to ACTH found in our study are consistent with Ldlr up-regulation reported in vitro following 24 h ACTH treatment in Y1 mouse adrenal cells [25]. Conversely, while Scarb1 have also been reported to be up-regulated by 24 h ACTH treatment in Y1 mouse adrenal cells [25], and to a larger extent than Ldlr, we did not find change in Scarb1 expression. Our results indicate that receptor-mediated endocytic uptake of LDL-cholesterol may be a more important source of cholesterol for adrenal steroidogenesis in pigs as is the case in humans [48], while it appears to play a negligible role in mouse [45]. Moreover, this is the first evidence indicating in vivo that the acute response to ACTH may involve cellular cholesterol supply for steroidogenesis via Ldlr regulation. A large number of genes found to be differentially expressed in our study encode transcription factors. Most of them have not been yet described as requisite in transcription networks involved in adrenal steroidogenesis. Nevertheless, they are potential interesting candidates, particularly those that were affected by both genotype and ACTH treatment. We were particularly interested in peripheral clock genes (such as Bmal1, Per2, Cry1), because recent studies reported that in the adrenal they regulate a large number of genes involved in general cellular processes (e.g. protein synthesis) as well as in pathways related to major organ-specific function (e.g. corticosteroid biosynthesis) and probably adjust adrenal sensitivity to ACTH [49-51]. Interestingly, while Per2 and Cry1 were not differentially expressed in our study, Bmal1 gene showed less expression in MS pigs. Thus, we can not exclude that differences in the expression level of some clock genes may be involved in differences in basal cortisol levels and adrenal reactivity to ACTH between MS and LW pigs. Further studies are needed to investigate other clock genes and to clarify how clock-controlled transcriptional rhythms in adrenals could contribute to the differences observed between both lines of pigs. Phosphorylation and dephosphorylation mechanisms might be also involved in the difference of adrenal function between LW and MS pigs because a large number of differentially expressed genes encode diverse protein kinases and protein phosphatases. Among them Snf1lk (SIK1 protein) constitute a valuable candidate since it was reported to be an important regulator in the early phase of ACTH-signaling in the adrenal cortex [52].

Conclusion

In conclusion, we report differential gene expression in adrenal in two lines of pigs in basal conditions and following acute ACTH treatment. Some of the genes have been already reported to be implicated in adrenal physiology, but the majority has not been documented as directly involved in steroidogenesis regulation or as acutely ACTH-responsive. Although their contributions to adrenal function merit further investigation, we may speculate on the involvement of a few of them. The higher cortisol levels in basal state and in response to ACTH in MS than in LW pigs was probably not triggered by changes in gene expression of known key regulator proteins of the ACTH signaling pathway and steroidogenic enzymes. However, a higher TCA cycle activity in MS pigs than in LW pigs may explain the higher steroidogenic activity by supplying more reducing equivalents and heme to steroidogenic enzymes. Alternately, differences in the adrenal function between MS and LW pigs involve likely mechanisms requisite for cholesterol supply to steroidogenesis. The genes described in this report are thus excellent potential candidates to mediate the genetic differences in adrenal steroidogenesis, particularly those affected by genotype and ACTH. Because dysregulation of glucocorticoid production results in diverse diseases, elucidation of the function of these genes in adrenals will lead to better understanding the molecular basis of such pathological conditions.

Methods

Animals and housing

Seven-week-old male Large White (LW) and Meishan (MS) piglets (n = 24) were used in this study. The animals were reared and experiments were conducted at the INRA experimental research farm of Le Magneraud (Surgères, France). Piglets were weaned at four weeks of age and then allocated into groups of 24 animals in 3.65 × 1.70 m pens. Animals were housed in collective pens on a 10 h light, 14 h dark cycle (natural photoperiod) with food and water ad libitum. Experimental groups of six pigs of both genotypes were randomly constituted and placed in collective pens one week before the experiments. For each genotype, pigs used in this study were taken from five litters resulting from matings with two boars. The experiments described here fully comply with legislation on research involving animal subjects according to the European Communities Council Directive of November 24, 1986 (86/609/EEC). Investigators were certificated by the French governmental authority for carrying out these experiments.

Treatment and sampling

Piglets were either non-treated or injected in the neck muscle with mammalian 1–24 ACTH (Immediate Synachten, Novartis France) at the dose of 250 μg per animal. The dose of ACTH was chosen to ensure a maximum cortisol release [30]. Non-treated animals have been chosen as control instead of animals injected with vehicle in order to have the most accurate basal conditions. In accordance with approved slaughter methods, piglets were stunned and immediately exsanguinated after capture from their home pen (non-treated animals) or one hour following ACTH injection. Experiments were performed between 08.00 h and 10.00 h. Blood samples were collected directly from each piglet in heparined tubes at sacrifice. The blood was kept on ice until centrifugation (4000 g for 10 min) and plasma frozen at -80°C until measurement of cortisol. The adrenal glands were also collected, frozen immediately on dry ice and then stored at -80°C until RNA isolation.

Cortisol measurement

Plasma total cortisol was measured using a specific radio immunoassay (as previously described in Désautés et al [7]). The cortisol data were transformed to base 10 logarithmic scores and analyzed by ANOVA to assess the effects of genotype, treatment and their interaction. Results are given as the mean ± standard error.

Total RNA isolation and purification

For each biological sample, entirely left adrenal gland was homogenized in TRIzol reagent (Invitrogen Life Technologies) and a part of the homogenized sample was then used for total RNA isolation, followed by column purification (RNeasy MinElute kit, Qiagen). This procedure ensures to get equal proportions of cortex and medulla between samples. DNA was digested using an RNase-free DNase set (Qiagen) during RNA purification. Total RNA was quantified by spectrophotometer (NanoDrop®) and its integrity was assessed on an Agilent 2100 Bioanalyser (RNA 6000 Nano LabChip, Agilent Technologies).

Microarray analysis

Gene expression was analyzed by hybridization of non commercial nylon cDNA microarrays (accession in Gene Expression Omnibus data sets: GPL3729) developed by the Biological Resources Center GADIE (Genomic for animals of economical importance, INRA France) and consisted of PCR products from 8959 cDNA clones [53]. cDNA from luciferase was present on the array as positive control (193 spots) and water was also included as negative control (64 spots). cDNA clones came from pig normalized multi-tissues libraries including adrenal glands collected from control and stress pigs. Microarrays were first hybridized with a 33P-labeled oligonucleotide sequence common to all PCR products to control the quality of spotting and quantity of target DNA accessible in each spot. Microarrays were then hybridized with 33P-labeled complex probes synthesized and labelled from 5 μg of total RNA with Supersript II RNAse H- reverse transcriptase (Invitrogen). mRNA from luciferase were added to the pigs samples for calibration. Hybridizations were carried out during 24 hours at 68°C. After washing, arrays were exposed for six to 12 hours to radioisotopic-sensitive imaging plates. Detection scanning was done with a FUJI BAS 5000 phosphoimager (Fujifilm) at 25-μm resolution and quantification of hybridization signals with the AGScan software [54]. One microarray hybridization per animal was done giving six biological replicates per experimental point.

Microarray data normalization and statistical analysis

Before statistical analysis, data were log10 transformed and centred by median for each array and each gene. A filter procedure eliminated non informative transcripts on the basis of being well measured (expression level > mean + 2 standard deviations of background signal) in 100% of the samples. Statistical analyses were done using the R software (version 2.2.1, [55]). A linear model was used to test the effect of genotype and treatment as well as their interaction, and variation in quantity of target DNA accessible in each spot was included as covariate. False discovery rate (FDR) was determined using the Benjamini-Hochberg procedure [56]. The microarray data from this research has been deposited in the NCBI Gene Expression Omnibus data repository under accession number GSE8377[57].

Functional annotation

Transcripts significantly affected by genotype and/or ACTH treatment were annotated for their function according to Gene Ontology database [58] and Expression Analysis Systematic Explorer (EASE) software from DAVID bioinformatics database [59].

Analysis of RNA changes by relative quantitative real-time PCR

To verify changes in gene expression, real-time PCR was carried out on 22 selected genes. RNA (4 μg) was reverse transcribed in a total volume of 20 μl using 200U of Superscript II (Invitrogen) reverse transcriptase, 100 pmol oligo-dT22V, 0.5 mM deoxy-NTP, and 40U RNasin (Promega). The resultant cDNA was diluted 1:100 with nuclease-free water. Five microliters of diluted cDNA was used in subsequent PCR reactions. All primers were designed based on nucleotide sequences in Genbank using the Primer Express software (PE Applied Biosystems) (table 3). PCR reaction efficiency was calculated for each primer pair with five dilution points of the calibrator sample to validate primers. Introns-exons organisation of the porcine genes was deduced by comparison with human genes using ICCARE software and primers from one pair were chosen in distinct exons of the corresponding gene. Each real-time PCR reaction consisted of 1× Power SYBR Green PCR Master Mix (PE Applied Biosystems), 0.5 μM forward and reverse primers and cDNA to a total volume of 20 μl. Reactions were carried out on an ABI PRISM 7500 Sequence detection system (PE Applied Biosystems) for 40 cycles (95°C for 15 s, 60°C for 1 min). The fold change in expression of each gene was calculated using the ΔΔCt method with the levels of transketolase RNA as an internal control; as determined by quantitative RT-PCR, the levels of transketolase did not change depending on genotype or treatment in our study (data not shown) and transketolase gene has previously been used to normalize data from quantitative RT-PCR in adrenal cells [25]. Quantitative real-time PCR analysis was done in each out of the six animals constituting an experimental point and measurements were done in duplicate. ANOVA was conducted on relative expression to assess the effects of genotype, treatment and their interaction.
Table 3

Gene-specific primers used for quantitative RT-PCR

Gene symbolForward PrimerReverse Primeraccession no.
Dab2CCCGTGATGTGACAGACAACCACTAATGGCTCTGCCTGTTGCBX918681
A2mACGTGAGCCGAACAGAGGTCGCGATGGCAAACTCAGCTGBX674240
AnpepCTCATTCGGAAGCAAGACGCCCACCGCCATAGTCCTGAAABX665286
Fxc1TCCTTCCAGGAGGCCTGTCGCTGTACCAGGGCAGGCATBX674767
Rnf2CACTGTGTTAAATGGCTCTTTTTCTTTGTGCTCCTTTGTGGGTGCBX673517
Gadd45bGCTGATGAATGTGGACCCTGACCTGACACCCGCACGATATCBX671980
Eif1bGTTTCTCTTGGAGGTTGGCATTTCACGAGGCAGCCAAACTGBX926052
CremAACACGCAAACGAGAGCTGAGGCACAGCCACACGGTTTTCBX670994
TktGGACAGGAAGCTCATTCTCGAAGCAGCCACTGCCTCACCTABX925610
StarGAAGAGCTTGTGGAGCGCATAGCCAACTCATGGGTGATGACU53020
Scarb1TGTGGTTTGCAGAGAGCGGATGAACAGCAGGACGCAGCNM_213967
Cyp21TGCTTCACCACCCTGAGATTCGCCCAGCTCGCGATCTAACBX916139
Cyp11a1AGACACTGAGACTCCACCCCAGACGGCCACTTGTACCAATGTBX674077
LdlrGCCTCACAGGCTCGGACATAACACCAGTTCACCCCTCTCGBX673438
SqleTGGTCCAGTTGCGCTGATTGGGCTCCGATTTAAAGCAAAABX920102
BzrpGGCACACTCTACTCGGCCATACAGCCTCCTCCGAGAAGCTBX925849
CkbTTCACCCGCTTCTGCAATGAGGTCAGGATGTAGCCCAGGTBX920566
Hsd3b1TTCCGCCCTCTCTGAGGTACTGGTCACGAAGTGGCGATTGBX919321
Bmal1TCCTAGCCAACGTCCTGGAATCTTTGGGCCACCTTCTCCEF216896
Cry1TGAACCACGCTGAGGCAAGGGATTAGATGGCACTGACGCABQ600826
Per2GACGTGCCGGAATGTGTTTACGCTCCCGGTTTCTGTGACTCCF789448
Mc2rACCATGTCCCCGCAGTGATGTGATGGCCCCTTTCATGTTAF450083
Cyp11bCCCGTGGGTATCTTCTTGGAGGTTTCGACCCAGGGAGTAGAD38590

Gene-specific primers were designed based on sequences provided under the accession numbers listed in the National Center for Biotechnology Information (NCBI) database.

Gene-specific primers used for quantitative RT-PCR Gene-specific primers were designed based on sequences provided under the accession numbers listed in the National Center for Biotechnology Information (NCBI) database.

Abbreviations

ACTH, adrenocorticotropic hormone; Alas1, aminolevulinate delta synthase 1; Bmal1 (or Arntl), Brain and muscle ARNT-like 1 (or aryl hydrocarbon receptor nuclear translocator-like protein 1); Bzrp (or TSPO), peripheral-type benzodiazepine receptor (or translocator protein); CBG, corticosteroid-binding globulin; Crem, cAMP responsive element modulator; CRH, corticotropin-releasing hormone; Cry1, cryptochrome 1; Cyp11a1, cytochrome P450 family 11 subfamily B polypeptide 1; Cyp11b, cytochrome P450 family 11 subfamily B; Cyp17, cytochrome P450 family 17; Cyp21, cytochrome P450 family 21; ERK, extra-cellular signal regulated kinase; Fxc1, fracture callus 1 homolog (rat); Hmgcr, hydroxymethylglutaryl coenzymeA reductase; HPA, hypothalamic-pituitary-adrenal; 3βhsd (or Hsd3b1), 3β hydroxysteroid dehydrogenase; Ldlr, low density lipoprotein receptor; LW, Large White; MAPK, mitogen activating protein kinase; Mc2r, melanocortin 2 receptor; Mdh2, malate dehydrogenase 2 NAD (mitochondrial); MS, Meishan; P450scc, cytochrome P450 cholesterol side chain cleavage enzyme; Per2, period homolog 2; Rnf2, ring finger protein 2; Scarb1, scavenger receptor beta 1; Sdha, succinate dehydrogenase complex subunit A flavoprotein (Fp); Snf1lk, SNF1-like kinase; Sqle, squalene epoxidase; Star, steroidogenic acute regulator; Suclg2, succinate-CoA ligase GDP-forming beta subunit; TCA, tricarboxylic acid.

Authors' contributions

DH was involved in experimental design and in planning the study, carried out experiments on animals, performed radioimmunoassay, extracted RNA, carried out microarray molecular work and real-time PCR work, performed statistical analysis, interpreted data and drafted the paper. LL was involved in the microarray molecular work, contributed to the statistical analyses of the microarray data and to the writing of the manuscript. MSC designed and performed statistical analyses of microarray data and contributed to the writing of the manuscript. PM conceived of the study and coordinated the experimental design, carried out experiments on animals, contributed to the RNA extraction and to the microarray molecular work, to the analysis and interpretation of data, and to writing the paper. All authors have read and approved the final manuscript.

Additional file 1

Complete list of genes differentially expressed depending on genotype and/or ACTH treatment. The data include one table. Click here for file

Additional file 2

Means and standard errors (SE) of transcripts levels (log) and Pearson correlation coefficients between real-time PCRs and microarray data. The data include one table. Click here for file
  54 in total

1.  Adrenal responses in high and low ACTH response lines of chickens during acute heat stress.

Authors:  F W Edens; H S Siegel
Journal:  Gen Comp Endocrinol       Date:  1975-01       Impact factor: 2.822

2.  Twenty-four-hour rhythmic gene expression in the rhesus macaque adrenal gland.

Authors:  Dario R Lemos; Jodi L Downs; Henryk F Urbanski
Journal:  Mol Endocrinol       Date:  2006-01-26

Review 3.  Physiology and neurobiology of stress and adaptation: central role of the brain.

Authors:  Bruce S McEwen
Journal:  Physiol Rev       Date:  2007-07       Impact factor: 37.312

4.  Regulation by adrenocorticotropin (ACTH), angiotensin II, transforming growth factor-beta, and insulin-like growth factor I of bovine adrenal cell steroidogenic capacity and expression of ACTH receptor, steroidogenic acute regulatory protein, cytochrome P450c17, and 3beta-hydroxysteroid dehydrogenase.

Authors:  C Le Roy; J Y Li; D M Stocco; D Langlois; J M Saez
Journal:  Endocrinology       Date:  2000-05       Impact factor: 4.736

Review 5.  Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH.

Authors:  E R Simpson; M R Waterman
Journal:  Annu Rev Physiol       Date:  1988       Impact factor: 19.318

6.  Heme availability affects corticosterone and aldosterone biosynthesis in rat adrenal.

Authors:  C N Martini; S G Vaena de Avalos; D G Romero; L San Martín de Viale; M de C Vila
Journal:  Steroids       Date:  1997-12       Impact factor: 2.668

7.  Consistent capacity for adrenocortical response to ACTH administration in pigs.

Authors:  D P Hennessy; T Stelmasiak; N E Johnston; P N Jackson; K H Outch
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

8.  The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype.

Authors:  X Bertagna; J Coste; M C Raux-Demay; M Letrait; G Strauch
Journal:  J Clin Endocrinol Metab       Date:  1994-08       Impact factor: 5.958

9.  Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level.

Authors:  F Gómez; A Lahmame; E R de Kloet; A Armario
Journal:  Neuroendocrinology       Date:  1996-04       Impact factor: 4.914

10.  Comparison of the neuroendocrine responses to stress in outbred, inbred and F1 hybrid rats.

Authors:  A Sarrieau; F Chaouloff; V Lemaire; P Mormède
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

View more
  7 in total

1.  Differential protein expression profile in the hypothalamic GT1-7 cell line after exposure to anabolic androgenic steroids.

Authors:  Freddyson J Martínez-Rivera; Juliana Pérez-Laspiur; María E Santiago-Gascot; Abner G Alemán-Reyes; Emanuel García-Santiago; Yolanda Rodríguez-Pérez; Cristhian Calo-Guadalupe; Inelia Otero-Pagán; Roxsana N Ayala-Pagán; Magdiel Martínez; Yisel M Cantres-Rosario; Loyda M Meléndez; Jennifer L Barreto-Estrada
Journal:  PLoS One       Date:  2017-07-18       Impact factor: 3.240

2.  Gene array analysis of adrenal glands in broiler chickens following ACTH treatment.

Authors:  Clara Bureau; Christelle Hennequet-Antier; Michel Couty; Daniel Guémené
Journal:  BMC Genomics       Date:  2009-09-14       Impact factor: 3.969

3.  The EADGENE and SABRE post-analyses workshop.

Authors:  Florence Jaffrezic; Jakob Hedegaard; Magali Sancristobal; Christophe Klopp; Dirk-Jan de Koning
Journal:  BMC Proc       Date:  2009-07-16

4.  Predicting qualitative phenotypes from microarray data - the Eadgene pig data set.

Authors:  Christèle Robert-Granié; Kim-Anh Lê Cao; Magali Sancristobal
Journal:  BMC Proc       Date:  2009-07-16

5.  Using microarrays to identify positional candidate genes for QTL: the case study of ACTH response in pigs.

Authors:  Vincent Jouffe; Suzanne Rowe; Laurence Liaubet; Bart Buitenhuis; Henrik Hornshøj; Magali SanCristobal; Pierre Mormède; D J de Koning
Journal:  BMC Proc       Date:  2009-07-16

6.  Time course of the response to ACTH in pig: biological and transcriptomic study.

Authors:  Valérie Sautron; Elena Terenina; Laure Gress; Yannick Lippi; Yvon Billon; Catherine Larzul; Laurence Liaubet; Nathalie Villa-Vialaneix; Pierre Mormède
Journal:  BMC Genomics       Date:  2015-11-17       Impact factor: 3.969

7.  Muscle transcriptomic investigation of late fetal development identifies candidate genes for piglet maturity.

Authors:  Valentin Voillet; Magali SanCristobal; Yannick Lippi; Pascal G P Martin; Nathalie Iannuccelli; Christine Lascor; Florence Vignoles; Yvon Billon; Laurianne Canario; Laurence Liaubet
Journal:  BMC Genomics       Date:  2014-09-17       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.